Correction to: Seminars in Immunopathology
Unfortunately, an error occurred in the following passus of the article. The word “receptor” was missing in the sentence “Because T cells do not express GM-CSF receptor [41], GM-CSF affects non-T cells.”
The corrected text is given below.
GM-CSF, a key pathogenic cytokine in autoimmune tissue inflammation
GM-CSF is recently highlighted as the pathogenic cytokine of Th17 cells. The role of GM-CSF in EAE model was first reported in 2001, in which blockade of GM-CSF showed resistance to the EAE induction, but the critical source of GM-CSF in immune cells was not investigated in detail [50]. There was the first report that among Th subsets infiltrating into the CNS after EAE induction, some of Th cells showed IL-17A+ GM-CSF+ double-positive producer [51]. The critical function of IL-23 signaling directing encephalitogenic Th17 cells has been reported to drive GM-CSF production, which causes local tissue inflammation [41, 52]. Because T cells do not express GM-CSF receptor [41], GM-CSF affects non-T cells. GM-CSF first acts on CNS-infiltrating myeloid cells such as dendritic cells (DCs), monocytes, and macrophages which in turn secrete pro-inflammatory cytokines such as IL-6 and IL-23, both of which upregulate IL-23R expression, amplifying IL-23-mediated pathogenic circuit to directly cause neurological pathogenicity and establishing local tissue inflammation by recruiting inflammatory macrophages in the CNS [51, 53]. GM-CSF also activates CCR2+ monocytes, monocyte-derived DCs, and microglia in the brain to produce IL-1β [54, 55]. Since microglia have a potential to produce IL-23, they could participate in the IL-23-IL-17 immune axis in Th17 cell–mediated tissue inflammation [56].
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s00281-019-00733-8
Rights and permissions
About this article
Cite this article
Yasuda, K., Takeuchi, Y. & Hirota, K. Correction to: The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol 41, 299 (2019). https://doi.org/10.1007/s00281-019-00746-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-019-00746-3